共 24 条
- [1] Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1250 - 1263
- [3] Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S097 - S098
- [8] Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (05): : 673 - 676
- [9] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309